Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Painful neuropathies.

Claudia Sommer1

  • 1Department of Neurology, University of Würzburg, Würzburg, Germany. sommer@mail.uni-wuerzburg.de

Current Opinion in Neurology
|September 23, 2003
PubMed
Summary
This summary is machine-generated.

Understanding neuropathic pain is advancing, with ongoing research into cellular changes and new treatments. However, access to effective pain management remains a challenge for many patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Specific HLA-DRB1 Alleles Associate With Anti-Caspr1 and Anti-CNTN1 Autoantibodies in Autoimmune Nodopathies.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

Consensus Definitions of Disease Activity and Clinical Outcomes in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy.

Neurology·2026
Same author

Intraepidermal nerve fiber density as a predictor of cardiac events in Fabry disease.

European heart journal open·2026
Same author

Polyclonal glycine receptor aAbs: a challenge for personalized epitope characterization.

Frontiers in molecular neuroscience·2026
Same author

A Next-Generation ELISA for the Detection of Anti-(Para)Nodal Antibodies in Autoimmune Nodopathy and COVID-19 Vaccinated Individuals.

Journal of the peripheral nervous system : JPNS·2026
Same author

Myalgia with the presence of pathologic EMG correlates with perimysial inflammatory infiltrates.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same journal

Movement disorders and Parkinson's disease: collaborative and interdisciplinary research to advance understanding of neural circuit dysfunction, pathophysiology, and care: new horizons in technology, neuroimaging, neurophysiology, and genetics toward personalized medicine.

Current opinion in neurology·2026
Same journal

Editorial introduction.

Current opinion in neurology·2026
Same journal

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026
Same journal

Tourette syndrome: brain neurophysiology, circuit dysfunction, and neuromodulation across invasive and noninvasive approaches.

Current opinion in neurology·2026
Same journal

Dystonia: from phenotypes to genetics and therapeutic advances.

Current opinion in neurology·2026
Same journal

What can we learn from eye movements in movement disorders and Parkinson's disease?

Current opinion in neurology·2026
See all related articles

Area of Science:

  • Neurology
  • Pain Medicine
  • Molecular Biology

Background:

  • Neuropathic pain arises from nerve damage, presenting complex challenges in assessment and treatment.
  • Recent research focuses on identifying specific pathomechanisms underlying painful neuropathies.

Purpose of the Study:

  • To review current knowledge on clinical assessment, pathophysiology, and treatment of neuropathic pain.
  • To highlight recent advancements in understanding pain mechanisms in selected neuropathies.

Main Methods:

  • Literature review of recent studies on neuropathic pain.
  • Analysis of cellular and molecular changes following nerve injury.
  • Examination of clinical trial data for neuropathic pain treatments.

Main Results:

Related Experiment Videos

  • Nerve injury triggers cellular changes, including altered sodium channel distribution and neuronal hyperexcitability, contributing to pain.
  • Inflammatory mediators and second messenger pathways are implicated in neuropathic pain development.
  • Despite moderate drug efficacy, many patients lack access to adequate neuropathic pain treatment.

Conclusions:

  • Standardized assessment methods are improving clinical study design for neuropathic pain.
  • While cellular and molecular mechanisms of neuropathic pain are increasingly understood, their direct relevance to pain pathophysiology requires further determination.